Anika Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	116.26	112.82	119.91	120.79	113.83	147.79
Revenue Growth (YoY)	36.52%	-5.91%	-0.73%	6.12%	-22.98%	13.29%
Cost of Revenue	48.14	49.01	43.91	38.26	40.61	64.85
Gross Profit	68.12	63.81	76	82.53	73.22	82.94
Selling, General & Admin	53.95	49.09	55.56	59.93	51.23	74.1
Research & Development	26.42	25.77	25.54	21.76	18.32	27.33
Other Operating Expenses	-	0	0	0	0	-21.1
Total Operating Expenses	80.38	74.86	81.1	81.69	69.55	80.33
Operating Income	-12.26	-11.05	-5.1	0.84	3.67	2.62
Interest Income	2	1.74	2.34	2.31	0.65	-0.19
Total Non-Operating Income (Expense)	2	1.74	2.34	2.31	0.65	-0.19
Pretax Income	-10.26	-9.31	-2.76	3.16	4.32	2.43
Provision for Income Taxes	0.82	0.67	6.06	6.6	2.12	-1.71
Net Income	-11.06	-10.88	-56.39	-82.67	-14.86	4.13
Earnings From Discontinued Operations	0.01	-0.9	-47.56	-79.23	-17.06	-
Net Income to Common	-11.06	-10.88	-56.39	-82.67	-14.86	4.13
Shares Outstanding (Basic)	14	14	15	15	15	14
Shares Outstanding (Diluted)	14	14	15	15	15	15
Shares Change (YoY)	-2.33%	-2.60%	0.44%	-0.89%	1.05%	2.90%
EPS (Basic)	-0.68	-0.70	-0.60	-0.23	0.15	0.29
EPS (Diluted)	-0.69	-0.70	-0.60	-0.23	0.15	0.28
EPS Growth	-	-	-	-	-46.43%	-
Shares Outstanding	13.36	13.89	14.42	14.66	14.63	14.44
Free Cash Flow	1.04	4.36	-2.33	-7.22	-3.08	3.25
Free Cash Flow Growth	-76.18%	-	-	-	-	-71.55%
Free Cash Flow Per Share	0.07	0.30	-0.16	-0.49	-0.21	0.22
Gross Margin	58.59%	56.56%	63.38%	68.33%	64.33%	56.12%
Operating Margin	-10.54%	-9.80%	-4.25%	0.70%	3.22%	1.77%
Profit Margin	-9.53%	-8.85%	-7.36%	-2.85%	1.93%	2.80%
FCF Margin	0.89%	3.87%	-1.94%	-5.97%	-2.70%	2.20%
EBITDA	-6.71	-5.32	3.02	15.06	18.16	23.4
EBITDA Margin	-5.77%	-4.72%	2.52%	12.47%	15.95%	15.83%
EBIT	-12.26	-11.05	-5.1	0.84	3.67	2.62
EBIT Margin	-10.54%	-9.80%	-4.25%	0.70%	3.22%	1.77%
Effective Tax Rate	-7.97%	-7.22%	-219.39%	208.97%	49.12%	-70.33%

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q